Cochrane Abstracts
First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension: Cochrane systematic review
First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension: Cochrane systematic review is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"First-line Drugs Inhibiting the Renin Angiotensin System Versus Other First-line Antihypertensive Drug Classes for Hypertension: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437296/all/First_line_drugs_inhibiting_the_renin_angiotensin_system_versus_other_first_line_antihypertensive_drug_classes_for_hypertension:_Cochrane_systematic_review. Accessed 04 July 2022.
First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437296/all/First_line_drugs_inhibiting_the_renin_angiotensin_system_versus_other_first_line_antihypertensive_drug_classes_for_hypertension:_Cochrane_systematic_review. Accessed July 4, 2022.
First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/437296/all/First_line_drugs_inhibiting_the_renin_angiotensin_system_versus_other_first_line_antihypertensive_drug_classes_for_hypertension:_Cochrane_systematic_review
First-line Drugs Inhibiting the Renin Angiotensin System Versus Other First-line Antihypertensive Drug Classes for Hypertension: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2022 July 04]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437296/all/First_line_drugs_inhibiting_the_renin_angiotensin_system_versus_other_first_line_antihypertensive_drug_classes_for_hypertension:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension: Cochrane systematic review
ID - 437296
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437296/all/First_line_drugs_inhibiting_the_renin_angiotensin_system_versus_other_first_line_antihypertensive_drug_classes_for_hypertension:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -
